TEGLUTIK susp 50 mg/10ml buvable fl 300 ml

7680664340013 CH-66434 N07XX02 01.99.0.
TEGLUTIK susp 50 mg/10ml buvable fl 300 ml
TEGLUTIK susp 50 mg/10ml buvable fl 300 ml
TEGLUTIK susp 50 mg/10ml buvable fl 300 ml
1 / 3
google

Details

Product number
6643401
CPT
-
Packaging group
300
Unit
ml
Composition
riluzolum 50 mg, arom.: saccharinum natricum, excipiens ad suspensionem pro 10 ml.

Articles (1)

Teglutik 50mg/10ml, suspension buvable
suspension
300
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
10/08/2022
Patient information leaflet
Français
10/08/2022
Patient information leaflet
Italien
10/08/2022
Professional SmPC
Allemand
09/08/2022
Professional SmPC
Français
09/08/2022
Professional SmPC
Italien
09/08/2022

Detailed composition

Substance Quantity Type Category
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance AIMDK

Reimbursement information

Public price
CHF 127.35
Specialties list
Yes
Generic
No
SL addition date: 01/10/2018

Authorization holder

EFFIK SA

1260 Nyon

Authorization information

Swissmedic authorization number
66434
Drug name
Teglutik, suspension buvable
Galenic form
SUOR
ATC Code
N07XX02
Authorization status
Z
Dispensation category
B
First authorization
26/04/2018
Authorization expiration date
31/12/9999
IT number
01.99.0.
Domain
Human medicine

Packaging details

Description (FR)
TEGLUTIK susp 50 mg/10ml buvable fl 300 ml
Description (DE)
TEGLUTIK Susp 50 mg/10ml zum Einnehmen Fl 300 ml
Market launch
26/04/2018
Narcotic (BTM)
No